Estimating Risk of Guillain-Barré Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-Controlled Case Series Analysis

Journal:
Clinical Infectious Diseases
Published:
DOI:
10.1093/cid/ciaf621
Affiliations:
3
Authors:
9
Go to article
Institutions Authors Share
Pfizer, United States of America (USA)
6.000000
 0.67
ADVI Health, United States of America (USA)
2.000000
 0.22
Pfizer Ireland Pharmaceuticals, Ireland
1.000000
 0.11
Interested in Medical Microbiology?